Was Medicxi the company that approached Starpharma last year regarding Antibody drug conjugates
If you recall Jackie talked about a well respected health care organisation at the 2023 AGM in November
Below is her comment
We were recently contacted by a very well respected health care organisation which had actually looked all around the world for technology which they could use to address certain problems associated an antibody drug conjugate which they are looking to develop and they had settled on the dendrimer technology as being able to provide that
If this is the case then this drug could be an ADC
We will find out tomorrow
Was Medicxi the company that approached Starpharma last year...
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 65000 | 1 |
View Market Depth
| Last trade - 16.12pm 25/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable